Zydus Lifesciences starts Phase IV clinical trials for novel drug #39;Desidustat#39;
The phase IV trial will enrol 1,004 chronic kidney disease (CKD) patients in India, including 502 dialysis dependent, 502 dialysis independent CKD patients with anaemia, the company said in a regulatory filing. Read More Top 100 Best Sellers